1. Nordic Council on Medicines (1987) Bioavailability studies in man, Nordic guidelines. Nordiska Läkemedelsnämnden, Uppsala (NLN Publ. No 18)
2. Junginger H (1987) APV-Richtlinie Untersuchungen zur Bioverfügbarkeit, Bioäquivalenz. Dtsch Apoth Z 127: 1645?48, Pharm Ind 49: 704?707
3. Bioequivalence Task Force (1988) Recommendations from the bioequivalence hearing conducted by the Food and Drug Administration, September 29?October 1, 1986. U.S. Food and Drug Administration, Rockville (Docket No. 86N-025)
4. Shuirmann DJ (1987) A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 15: 657?680
5. Scheffé H (1959) The analysis of variance. Wiley and Sons, Chichester Brisbane Toronto Singapore